Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1587497

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1587497

Asia Pacific Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration (Oral, Entreal), By Product (Powder, Pills), By Application, By Module, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Asia Pacific Medical Foods Market Growth & Trends:

The Asia Pacific medical foods market size is anticipated to reach USD 9.94 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.27% from 2025 to 2030. The rapid rate of urbanization and increasing geriatric population has created a need for managing diseases that affect the older population as well as those with sedentary lifestyles.

Based on route of administration, the oral segment accounted for the largest revenue share of 73.57% in 2024. The majority of the medical foods available are for oral consumption. The ease of administration and rising consumer demand contribute to the largest market share of this segment. The enteral route of administration registered the fastest CAGR of 6.6% from 2025 to 2030. The growing population suffering from diseases that render them unable to consume food orally has led to this growth. Enteral feeding has been proving effective in several cases, with better absorption of nutrients and lesser contamination rates.

In the product type segment, powder formulations recorded the largest revenue share of the market in 2024. The majority of product offerings currently available in the market are in powder formulations. Easy storage and longer shelf life of these products are one of the key factors leading to the wider adoption of this product type. The liquid formulations segment is expected to register the fastest growth over the forecast period, as the key players are diversifying their product portfolios to cater to larger populations. This segment is expected to have maximum growth potential in the medical foods industry.

In 2024, chemotherapy-induced diarrhea accounted for the largest revenue share in the application segment, due to the high burden of cancer and the need for proper management of the disease. Nutritional supplementation through medical foods has become necessary in the management of cancer, thus driving the growth in demand for medical foods in this segment. The diabetic neuropathy segment is expected to register the fastest CAGR during the forecast period. This is due to the rise in prevalence of the disease in the rapidly developing nations in the Asia Pacific (APAC) and the increasing demand for nutrient-rich foods for the management of this condition.

In 2024, institutional sales accounted for the largest revenue share in the sales channel segment. APAC is still an untapped space with a huge potential for growth, the primary channel for the purchase of medical foods is through doctors in clinics and health centers that rely on medical representatives which are hired by market players for distribution of the product. The online platform is expected to witness the fastest CAGR in the forthcoming years, due to the rising awareness about the benefits of medical foods in disease management. Major market players are increasing their reach by diversifying their distribution channels and collaborating to sell their medical foods products online, directly to consumers.

The COVID-19 pandemic adversely affected the growth of the APAC medical foods market, because the majority of the medical food products in the market are being imported from other countries, with the trade restrictions in place the supply chain was severely affected. The market is expected to pick up, as the demand for these products has been increasing due to the deteriorating health of people and the growing geriatric population.

Asia Pacific Medical Foods Market Report Highlights:

  • The oral route of administration accounted for the largest revenue share of 73.57% in 2024 as a result of high product type availability and ease of administration.
  • The powder formulations in product type had the largest revenue share of 35.88% due to ease of use and maximum product availability.
  • Diabetic neuropathy is expected to register the fastest growth in the application segment during the forecast period of 2025 - 2030. High disease burden and the need for proper management of the disease are key factors for growth.
  • Institutional sales is anticipated to grow significantly over the forecast period. The segment's growth is driven by increasing recommendations from doctors to use medical foods. Institutions that purchase medical foods include hospitals, long-term care centers, hospices, clinics, and disability facilities
Show more
Product Code: GVR-4-68039-942-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Route of Administration
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. Module
    • 1.1.5. Sales Channel
    • 1.1.6. Country scope
    • 1.1.7. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Route of administration outlook
    • 2.2.2. Product outlook
    • 2.2.3. Application outlook
    • 2.2.4. Module outlook
    • 2.2.5. Sales channel outlook
    • 2.2.6. Country outlook
  • 2.3. Competitive Insights

Chapter 3. Asia Pacific Medical Foods Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Asia Pacific Medical Foods Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. COVID-19 Impact

Chapter 4. Asia Pacific Medical Foods Market: Route of Administration Estimates & Trend Analysis

  • 4.1. Route of Administration Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Asia Pacific Medical Foods Market by Route of Administration Outlook
  • 4.4. Oral
    • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Enteral
    • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Asia Pacific Medical Foods Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Asia Pacific Medical Foods Market by Product Outlook
  • 5.4. Pills
    • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.5. Powder
    • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.6. Liquid
    • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.7. Others (semisolid, semiliquid)
    • 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Asia Pacific Medical Foods Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Asia Pacific Medical Foods Market by Application Outlook
  • 6.4. Chronic Kidney Disease
    • 6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.5. Minimal Hepatic Encephalopathy
    • 6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.6. Chemotherapy Induced Diarrhea
    • 6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.7. Pathogen Related Infections
    • 6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.8. Diabetic Neuropathy
    • 6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.9. ADHD
    • 6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.10. Depression
    • 6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.11. Alzheimer's Disease
    • 6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.12. Nutritional Deficiency
    • 6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.13. Orphan Diseases
    • 6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.2. Tyrosinemia
      • 6.13.2.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.3. Eosinophilic Esophagitis
      • 6.13.3.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.4. Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES))
      • 6.13.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.5. Phenylketonuria (PKU)
      • 6.13.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.6. Maple syrup urine disease (Maple syrup urine disease (MSUD))
      • 6.13.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.7. Homocystinuria
      • 6.13.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 6.13.8. Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)
      • 6.13.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.14. Wound Healing
    • 6.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.15. Chronic Diarrhea
    • 6.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.16. Constipation Relief
    • 6.16.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.17. Protein Booster
    • 6.17.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.18. Dysphagia
    • 6.18.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.19. Pain Management
    • 6.19.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.20. Parkinson's Disease
    • 6.20.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.21. Epilepsy
    • 6.21.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.22. Other Cancer related treatments
    • 6.22.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.23. Severe Protein Allergy
    • 6.23.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.24. Cancer
    • 6.24.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.25. Cachexia
    • 6.25.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.26. Other (debilitating conditions, COPD, etc.)
    • 6.26.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 7. Asia Pacific Medical Foods Market: Modules Estimates & Trend Analysis

  • 7.1. Modules Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Asia Pacific Medical Foods Market by Modules Outlook
  • 7.4. Amino Acid Module
    • 7.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.5. Protein Module
    • 7.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.6. Vitamin & Mineral Modules
    • 7.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.7. Fatty Acid based Modules
    • 7.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.8. Carbohydrate Modules
    • 7.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.9. Fiber Modules
    • 7.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.10. Ketogenic Modules
    • 7.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.11. Peptide based Modules
    • 7.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.12. Hypoallergic Modules
    • 7.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.13. Others (Electrolyte Module, etc.)
    • 7.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 8. Asia Pacific Medical Foods Market: Sales Channel Estimates & Trend Analysis

  • 8.1. Sales Channel Market Share, 2024 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Asia Pacific Medical Foods Market by Sales Channel Outlook
  • 8.4. DTC Sales Channel
    • 8.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 8.4.2. Online Sales
      • 8.4.2.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 8.4.3. Retail Sales
      • 8.4.3.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 8.5. Institutional Sales
    • 8.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 8.5.2. Hospitals
      • 8.5.2.1. Market estimates and forecast 2018 - 2030 (USD Million)
    • 8.5.3. Others (Long-term Care Facilities, etc.)
      • 8.5.3.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 9. Asia Pacific Medical Foods Market: Country Estimates & Trend Analysis, By Route of Administration, By Product, By Application, By Module, By Sales Channel

  • 9.1. Country Market Share Analysis, 2024 & 2030
  • 9.2. Country Market Dashboard
  • 9.3. Country Market Snapshot
  • 9.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.3. Australia
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.7. Vietnam
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Vietnam market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Innovators
  • 10.4. Vendor Landscape
    • 10.4.1. List of key distributors and channel partners
    • 10.4.2. Key customers
    • 10.4.3. Key company market share analysis, 2024
    • 10.4.4. Mead Johnson & Company, LLC
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Technology Type benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Nestle
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Technology Type benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Abbott
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Technology Type benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Danone
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Technology Type benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. SHS International ltd
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Technology Type benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Fresenius Kabi AG
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Technology Type benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Synutra International ltd
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Technology Type benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Milupa Gmbh
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Technology Type benchmarking
      • 10.4.11.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-942-7

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Asia Pacific medical foods market, by region, 2018 - 2030 (USD Million)
  • Table 3 Asia Pacific medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 4 Asia Pacific medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 5 Asia Pacific medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 6 Asia Pacific medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 7 Asia Pacific medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 8 Japan medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 9 Japan medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 10 Japan medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 11 Japan medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 12 Japan medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 13 China medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 14 China medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 15 China medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 16 China medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 17 China medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 18 Australia medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 19 Australia medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 20 Australia medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 21 Australia medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 22 Australia medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 23 India medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 24 India medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 25 India medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 26 India medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 27 India medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 28 South Korea medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 29 South Korea medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 30 South Korea medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 31 South Korea medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 32 South Korea medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 33 Thailand medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 34 Thailand medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 35 Thailand medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 36 Thailand medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 37 Thailand medical foods market, by sales channel, 2018 - 2030 (USD Million)
  • Table 38 Vietnam medical foods market, by route of administration, 2018 - 2030 (USD Million)
  • Table 39 Vietnam medical foods market, by product, 2018 - 2030 (USD Million)
  • Table 40 Vietnam medical foods market, by application, 2018 - 2030 (USD Million)
  • Table 41 Vietnam medical foods market, by modules, 2018 - 2030 (USD Million)
  • Table 42 Vietnam medical foods market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Asia Pacific medical foods market: market outlook
  • Fig. 9 Computer aided detection competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Asia Pacific medical foods market driver impact
  • Fig. 15 Asia Pacific medical foods market restraint impact
  • Fig. 16 Asia Pacific medical foods market strategic initiatives analysis
  • Fig. 17 Asia Pacific medical foods market: Route of administration movement analysis
  • Fig. 18 Asia Pacific medical foods market: Route of administration outlook and key takeaways
  • Fig. 19 Oral market estimates and forecast, 2018 - 2030
  • Fig. 20 Enteral market estimates and forecast, 2018 - 2030
  • Fig. 21 Asia Pacific medical foods market: Product movement analysis
  • Fig. 22 Asia Pacific medical foods market: Product outlook and key takeaways
  • Fig. 23 Pills market estimates and forecast, 2018 - 2030
  • Fig. 24 Powder market estimates and forecast, 2018 - 2030
  • Fig. 25 Liquid market estimates and forecast, 2018 - 2030
  • Fig. 26 Others (semisolid, semiliquid) market estimates and forecast, 2018 - 2030
  • Fig. 27 Asia Pacific medical foods market: Application model analysis
  • Fig. 28 Asia Pacific medical foods market: Application model outlook and key takeaways
  • Fig. 29 Chronic kidney disease market estimates and forecast, 2018 - 2030
  • Fig. 30 Minimal hepatic encephalopathy market estimates and forecast, 2018 - 2030
  • Fig. 31 Chemotherapy induced diarrhea market estimates and forecast, 2018 - 2030
  • Fig. 32 Pathogen related infections market estimates and forecast, 2018 - 2030
  • Fig. 33 Diabetic neuropathy market estimates and forecast, 2018 - 2030
  • Fig. 34 ADHD market estimates and forecast, 2018 - 2030
  • Fig. 35 Depression market estimates and forecast, 2018 - 2030
  • Fig. 36 Alzheimer's disease market estimates and forecast, 2018 - 2030
  • Fig. 37 Nutritional deficiency market estimates and forecast, 2018 - 2030
  • Fig. 38 Orphan diseases market estimates and forecast, 2018 - 2030
  • Fig. 39 Tyrosinemia market estimates and forecast, 2018 - 2030
  • Fig. 40 Eosinophilic Esophagitis market estimates and forecast, 2018 - 2030
  • Fig. 41 Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES)) market estimates and forecast, 2018 - 2030
  • Fig. 42 Phenylketonuria (PKU) market estimates and forecast, 2018 - 2030
  • Fig. 43 Maple syrup urine disease (Maple syrup urine disease (MSUD)) market estimates and forecast, 2018 - 2030
  • Fig. 44 Homocystinuria market estimates and forecast, 2018 - 2030
  • Fig. 45 Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) market estimates and forecast, 2018 - 2030
  • Fig. 46 Wound healing market estimates and forecast, 2018 - 2030
  • Fig. 47 Chronic diarrhea market estimates and forecast, 2018 - 2030
  • Fig. 48 Constipation relief market estimates and forecast, 2018 - 2030
  • Fig. 49 Protein booster market estimates and forecast, 2018 - 2030
  • Fig. 50 Dysphagia market estimates and forecast, 2018 - 2030
  • Fig. 51 Pain management market estimates and forecast, 2018 - 2030
  • Fig. 52 Parkinson's disease market estimates and forecast, 2018 - 2030
  • Fig. 53 Epilepsy market estimates and forecast, 2018 - 2030
  • Fig. 54 Other cancer related treatments market estimates and forecast, 2018 - 2030
  • Fig. 55 Severe protein allergy market estimates and forecast, 2018 - 2030
  • Fig. 56 Cancer market estimates and forecast, 2018 - 2030
  • Fig. 57 Chacexia market estimates and forecast, 2018 - 2030
  • Fig. 58 Other (debilitating conditions, COPD, etc.) market estimates and forecast, 2018 - 2030
  • Fig. 59 Asia Pacific medical foods market: Module model analysis
  • Fig. 60 Asia Pacific medical foods market: Module model outlook and key takeaways
  • Fig. 61 Amino acid module market estimates and forecast, 2018 - 2030
  • Fig. 62 Protein module market estimates and forecast, 2018 - 2030
  • Fig. 63 Vitamin & mineral modules market estimates and forecast, 2018 - 2030
  • Fig. 64 Fatty acid based modules market estimates and forecast, 2018 - 2030
  • Fig. 65 Carbohydrate modules market estimates and forecast, 2018 - 2030
  • Fig. 66 Fiber modules market estimates and forecast, 2018 - 2030
  • Fig. 67 Ketogenic modules market estimates and forecast, 2018 - 2030
  • Fig. 68 Peptide based modules market estimates and forecast, 2018 - 2030
  • Fig. 69 Hypoallergic modules market estimates and forecast, 2018 - 2030
  • Fig. 70 Others (electrolyte module, etc.) market estimates and forecast, 2018 - 2030
  • Fig. 71 Asia Pacific medical foods market: Sales channel model analysis
  • Fig. 72 Asia Pacific medical foods market: Sales channel model outlook and key takeaways
  • Fig. 73 DTC sales channel market estimates and forecast, 2018 - 2030
  • Fig. 74 Online sales market estimates and forecast, 2018 - 2030
  • Fig. 75 Retail sales market estimates and forecast, 2018 - 2030
  • Fig. 76 Institutional sales market estimates and forecast, 2018 - 2030
  • Fig. 77 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 78 Others (long-term care facilities, etc.) market estimates and forecast, 2018 - 2030
  • Fig. 79 Asia Pacific medical foods market: Country movement analysis
  • Fig. 80 Asia Pacific medical foods market: Country outlook and key takeaways
  • Fig. 81 Asia Pacific medical foods market share and leading players
  • Fig. 82 Asia Pacific SWOT
  • Fig. 83 Asia Pacific
  • Fig. 84 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 85 China
  • Fig. 86 China market estimates and forecasts, 2018 - 2030
  • Fig. 87 Japan
  • Fig. 88 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 89 Australia
  • Fig. 90 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 91 India
  • Fig. 92 India market estimates and forecasts, 2018 - 2030
  • Fig. 93 South Korea
  • Fig. 94 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 95 Thailand
  • Fig. 96 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 97 Vietnam
  • Fig. 98 Vietnam market estimates and forecasts, 2018 - 2030
  • Fig. 99 Market share of key market players- Asia Pacific medical foods market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!